Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and ...

"I think I was cute before and I'm cute now," the ... prescription medication for people with Type 2 diabetes and is now dealing with hair loss as a side effect of the apparent weight loss.

referring to the class of drugs for weight loss that Wegovy and Zepbound, as well as related diabetes medicines Ozempic and Mounjaro, belong to. "There will be an expectation that those prices ...

The U.S. Food and Drug Administration is blocking sales of cheaper compounded versions of the drugs now that Wegovy and Zepbound and their related diabetes ... embracing weight-loss drugs and ...

Popular obesity and diabetes ... of what's available to treat alcohol use disorder," Dr. Maurice O'Farrell, lead author of the study and founder of the Medication Weight Loss Clinic in Dublin ...